用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
SQUIBB BRISTOL MYERS CO [US](10)
Ohio University(10)
PLIVA LACHEMA AS [CZ](8)
TAIHO PHARMACEUTICAL CO LTD [JP](7)
BRISTOL-MYERS SQUIBB COMPANY(6)
MAX DELBRUECK CENTRUM [DE](6)
Prometic Biosciences Inc.(6)
Pliva-lachema A.s.(6)
KOSAN BIOSCIENCES INC [US](5)
PHARMACHEMIE BV [NL](4)
专利信息
Translation Company
查询条件
展开筛选条件
[药品] 包含 'Carboplatin'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
3
4
5
6
下页
尾页
共
312
条记录, 当前第1/32页。
公开号
公开日
申请号
申请日
1.
US2014072643A1
2014/3/13
US201313782990
2013/3/1
专利标题
:METHODS OF TREATING CANCER
专利权人
:
ABRAXIS BIOSCIENCE LLC [US]
;
ABRAXIS BIOSCIENCE LLC [US]
;
The present invention provides methods and compositions for treating non-small-cell lung cancer (NSCLC) by administering a) a composition comprising nanoparticles that comprise paclitaxel and an albumin and b) a platinum-based agent (e.g., carboplatin). The present application also provides methods of treating prostate cancer by administering to the individual a) an effective amount of a composition comprising nanoparticles comprising docetaxel and an albumin
2.
US2014057851A1
2014/2/27
US201313969763
2013/8/19
专利标题
:Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma
专利权人
:
YLA-HERTTUALA SEPPO [FI]
;
WKD HOLDING OY [FI]
;
Anti-angiogenic gene therapy with a combination of soluble Vascular Endothelial Growth Factors (sVEGFR) improves the efficacy of chemotherapy with paclitaxel for reducing ovarian cancer mean tumor volume (in cubic millimetres) as measured using magnetic resonance imaging. The study groups were: AdLacZ control, combination of AdsVEGFR-1, -2 and -3, combination of AdsVEGFR-1, -2, -3 and paclitaxel, bevacizumab monotherapy, paclitaxel monotherapy and carboplatin monotherapy. Effectiveness was asses...
3.
US20140057851A1
2014/2/27
专利标题
:Anti-angiogenic gene therapy with soluble vegf receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma
专利权人
:
Wkd Holding Oy
;
Anti-angiogenic gene therapy with a combination of soluble Vascular Endothelial Growth Factors (sVEGFR) improves the efficacy of chemotherapy with paclitaxel for reducing ovarian cancer mean tumor volume (in cubic millimetres) as measured using magnetic resonance imaging. The study groups were: AdLacZ control combination of AdsVEGFR-1 -2 and -3 combination of AdsVEGFR-1 -2 -3 and paclitaxel bevacizumab monotherapy paclitaxel monotherapy and carboplatin monotherapy. Effectiveness was assessed by ...
4.
JP2013544799A
2013/12/19
JP20130535215
2011/10/26
专利标题
:
专利权人
:
New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...
5.
CN103435494A
2013/12/11
CN20131325599
2013/7/30
专利标题
:Preparation method of N-ethyl cyclohexylamine
专利权人
:
SUZHOU GLOBALTECH NEW MATERIAL CO LTD
;
6.
KR20130132448A
2013/12/4
KR20137013238
2011/10/26
专利标题
:Compounds and compositions for the treatment of cancer
专利权人
:
Prometic Biosciences, Inc.
;
New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...
7.
EP2668949A1
2013/12/4
EP20130182512
2008/8/6
专利标题
:Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
专利权人
:
UNIV OHIO [US]
;
The present invention provides phosphaplatins, stable isolated monomeric phosphato complexes of platinum (II) and (IV), and methods of use thereof for treating cancers, including cisplatin- and carboplatin-resistant cancers. Unlike cisplatin, these complexes do not readily undergo hydrolysis and are quite soluble and stable in aqueous solutions. Moreover, these complexes - unlike cisplatin, carboplatin, and related platinum-based anti-cancer agents - do not bind DNA. Rather, data suggests that p...
8.
WO2013171287A1
2013/11/21
WO2013EP60098
2013/5/15
专利标题
:COMBINATION OF CD37 ANTIBODIES WITH ICE (IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE)
专利权人
:
BOEHRINGER INGELHEIM INT [DE]
;
The present invention relates to immunotherapies that are based on depletion of CD37- positive cells such as B-cells. The present invention provides methods for reduction of CD37-positive cells such as B-cells in an individual / patient using a combination of CD37 antibody /antibodies and ICE. The combination of CD37 antibodies and ICEis shown to have improved anti-tumor efficacy compared to single agent treatment. The application further provides materials and methods for treatment of diseases ...
9.
TW201345531A
2013/11/16
TW20130103610
2013/1/31
专利标题
:Combination therapy including isophosphoramide mustard, analogs, or salts thereof
专利权人
:
ZIOPHARM ONCOLOGY INC [US]
;
In one aspect, a method for treating a subject having a hyperproliferative disorder is disclosed, including administering to the subject a composition including: IPM, an IPM analog, or a pharmaceutically acceptable salt thereof in the dosage from about 70 mg/m
2
/day to about 160 mg/m
2
/day
10.
JP2013227218A
2013/11/7
JP20130120309
2013/6/7
专利标题
:PHOSPHAPLATIN AND ITS USE IN TREATMENT OF CANCER RESISTANT TO CISPLATIN AND CARBOPLATIN
专利权人
:
UNIV OHIO
;
首页
1
2
3
4
5
6
下页
尾页
共
312
条记录, 当前第1/32页。
当前查询条件: [药品] 包含 'Carboplatin'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文